VITAS CMO Shega: At-Risk Versions Can Foster Previously Accessibility, Easier Transitions to Hospice
Opportunities exist within risk-based repayment versions to enhance sychronisation amongst suppliers and also changes of treatment in between setups, according to Dr. Joseph Shega, executive vice head of state and also primary clinical policeman for VITAS Medical care, a subsidiary of Chemed Corp. (NYSE: CHEM). While the Medicare advantage covers the substantial bulk of hospice…